Huntsman (HUN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Huntsman (HUN) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Huntsman (HUN) Surpasses Q2 Earnings Estimates
Huntsman (HUN) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.22 per share a year ago.
Earnings Preview: Huntsman (HUN) Q2 Earnings Expected to Decline
Huntsman (HUN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Huntsman: A Strong Cyclical Play, But Patience Is The Key
Huntsman has a diversified product portfolio with stable demand in consumer discretionary and non-discretionary sectors. It faces a secular decline in sales despite consistent capital expenditures and inorganic growth initiatives. Management appears cautious in its outlook, focusing on improving cash flows, costs, and environmental performance.
Here's Why You Should Hold Onto Huntsman (HUN) Stock for Now
While Huntsman (HUN) faces headwinds from soft demand in specific markets and pricing pressures, it gains on actions to grow its downstream specialty and formulation businesses and synergies of acquisitions.
Huntsman (HUN) Gains on Downstream Expansion, Acquisitions
While Huntsman (HUN) faces headwinds from soft demand conditions, it benefits from investment in downstream businesses and differentiated product innovation as well as strategic acquisitions.
Huntsman (HUN) Unveils New Innovation Center in Belgium
The new 11,000-square-meter facility by Huntsman (HUN) includes a world-scale analytical laboratory, two machine halls and fully equipped and automated product testing areas.
Why You Should Retain Huntsman (HUN) Stock in Your Portfolio
While Huntsman (HUN) faces headwinds from demand weakness in certain markets and pricing pressures, it benefits from actions to grow its downstream specialty and formulation businesses and synergies of acquisitions.
